Vaishali Pharma Ltd vs Veerhealth Care Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Vaishali Pharma Ltd is ₹ 7.7 as of 04 May 10:09 . The P/E Ratio of Vaishali Pharma Ltd changed from 32.9 on March 2021 to 209.7 on March 2025 . This represents a CAGR of 44.84% over 5 yearsThe P/E Ratio of Veerhealth Care Ltd changed from 13.8 on March 2021 to 61.2 on March 2025 . This represents a CAGR of 34.70% over 5 years The Market Cap of Vaishali Pharma Ltd changed from ₹ 171.9 crore on March 2021 to ₹ 134.85 crore on March 2025 . This represents a CAGR of -4.74% over 5 yearsThe Market Cap of Veerhealth Care Ltd changed from ₹ 5.27 crore on March 2021 to ₹ 24.48 crore on March 2025 . This represents a CAGR of 35.96% over 5 years The Revenue of Vaishali Pharma Ltd is ₹ 24.59 crore as of Jun '25 .The Revenue of Veerhealth Care Ltd is ₹ 0 crore as of Jun '25 . The EBITDA of Vaishali Pharma Ltd is ₹ 2.21 crore as of Jun '25 .The EBITDA of Veerhealth Care Ltd is ₹ 0 crore as of Jun '25 . The Net Profit of Vaishali Pharma Ltd is ₹ 1.28 crore as of Jun '25 .The Net Profit of Veerhealth Care Ltd is ₹ 0 crore as of Jun '25 . The Dividend Payout of Vaishali Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Veerhealth Care Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Vaishali Pharma Ltd

Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name 'Vaishali Pharma Private Limited' on 25th, April 2008.
On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz.
M/s.
Vaishali Pharmachem through Business Assignment agreement.
Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited.

About Veerhealth Care Ltd

Veerhealth Care Limited was originally incorporated on 10 July, 1992 as Niyati Leasing Limited to start business in Investment and Finance.
The main objects of the Company in 1998 got changed and accordingly the name was changed from Niyati Leasing Limited to Niyati Industries Limited and from Niyati Industries Limited to Veerhealth Care Limited in May, 2013. Initially in 2010, the Company was engaged into dealing and trading of shares, securities, debentures, and other investments.
It wanted to start business in the field of infrastructure.
Later on, the Company through the Main Objects, diversify the business activities to Pharma sector in 2013.
Apart from Tablet, Syrup, Ointment, Powder, it also started manufacturing in the Oil, Shampoo, Ointment and Toothpaste Division in year 2015-16.

FAQs for the comparison of Vaishali Pharma Ltd and Veerhealth Care Ltd

Which company has a larger market capitalization, Vaishali Pharma Ltd or Veerhealth Care Ltd?

Market cap of Vaishali Pharma Ltd is 99 Cr while Market cap of Veerhealth Care Ltd is 41 Cr

What are the key factors driving the stock performance of Vaishali Pharma Ltd and Veerhealth Care Ltd?

The stock performance of Vaishali Pharma Ltd and Veerhealth Care Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Vaishali Pharma Ltd and Veerhealth Care Ltd?

As of May 4, 2026, the Vaishali Pharma Ltd stock price is INR ₹7.61. On the other hand, Veerhealth Care Ltd stock price is INR ₹20.63.

How do dividend payouts of Vaishali Pharma Ltd and Veerhealth Care Ltd compare?

To compare the dividend payouts of Vaishali Pharma Ltd and Veerhealth Care Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.